Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Sleep Medicine

Beyond the Snore: Long-Term Risks of Sleep Apnea

At a Glance

Sleep apnea can affect more than sleep: repeated airway collapse and oxygen drops are linked with high blood pressure, atrial fibrillation, stroke, heart failure, insulin resistance, and weight gain. Risk assessment considers apnea severity, oxygen levels, other conditions, and consistent CPAP use.

Obstructive Sleep Apnea (OSA) is a systemic disorder that is associated with effects in many parts of the body, extending beyond your lungs and airway [1]. While the immediate effects of a poor night’s sleep are frustrating, untreated OSA is linked to long-term risks, particularly for your heart and metabolism [2].

Common and “Hidden” Symptoms

The symptoms of OSA are often divided into what you feel during the day and what happens while you sleep. However, many patients experience “hidden” symptoms that they might not initially connect to their breathing [3]. (Note: These symptoms can have other causes. Have new or persistent symptoms evaluated by a doctor).

  • Excessive Daytime Sleepiness (EDS): This is more than just feeling tired; it is a heavy, sometimes overwhelming urge to sleep during quiet moments [4].
  • Morning Headaches: These often feel like a dull ache across the forehead and usually disappear within an hour of waking up [3].
  • Unrefreshing Sleep: Even after 8 or 9 hours in bed, you may wake up feeling like you haven’t slept at all [5].
  • Cognitive and Mood Changes: Repeated oxygen drops and sleep interruptions can lead to neurocognitive impairment [6]. This includes:
    • Impaired Vigilance: Difficulty staying focused or reacting quickly, which is especially dangerous when driving [7].
    • Memory Issues: Problems with short-term memory or “brain fog” [3].
    • Mood Disturbances: A strong link exists between OSA and depressive symptoms or irritability, particularly in patients who feel very sleepy during the day [8][5].

The Cardiovascular Connection

When your airway collapses, your oxygen levels drop (hypoxia), and your body enters a “fight or flight” state [9]. This causes a surge in adrenaline and a spike in blood pressure to force you to wake up and breathe [10]. Over time, these repeated events are associated with increased cardiovascular risk [2].

  • Resistant Hypertension: OSA is a very common factor in high blood pressure that does not respond well to medication [11]. A large percentage of people with drug-resistant hypertension also have OSA [11].
  • Atrial Fibrillation (AFib): OSA is a major risk factor for AFib, an irregular heart rhythm [12]. Untreated OSA is associated with higher rates of AFib recurrence even after medical procedures like ablation [13][14].
  • Heart Failure and Stroke: The constant pressure changes in your chest and the inflammation caused by low oxygen increase the risk of heart failure [15]. Observational studies suggest an association between higher Apnea-Hypopnea Index (AHI) scores and increased stroke risk [16]. While risk varies based on age, blood pressure, and other factors, severe OSA adds an additional burden to your heart.

Metabolic Risks and the Weight Gain Loop

OSA and your metabolism are closely linked in a “bidirectional” relationship, meaning each one can make the other worse [17].

  • Insulin Resistance: The stress of stopping breathing interferes with how your body processes sugar, leading to insulin resistance and an increased risk of type 2 diabetes [18][19]. This risk exists even if you are not overweight [20].
  • The Weight Gain Loop: Sleep deprivation disrupts the hormones that control hunger (ghrelin and leptin) [17]. This can lead to increased cravings and weight gain. Extra weight, especially around the neck, then further crowds the airway, making the sleep apnea more severe [21].

“Asymptomatic” OSA: Understanding the Risks

It is a common misconception that you must be “sleepy” to have OSA. Many patients with OSA do not report significant daytime sleepiness [4].

Even if you feel fine during the day, your body may still be experiencing the nightly oxygen drops associated with heart disease [1]. For these non-sleepy patients, the decision to pursue treatment depends on the severity of the apnea, the depth of oxygen drops, and other comorbidities. While CPAP reliably treats the airway obstruction, evidence regarding its ability to completely prevent heart attacks or strokes in non-sleepy patients is mixed [22]. Discuss your overall risk profile with your clinician. Studies show that if you do use CPAP therapy, the cardiovascular benefit depends heavily on using the machine consistently throughout the night, not just meeting minimum insurance compliance [23][24].

Common questions in this guide

Can untreated obstructive sleep apnea raise my blood pressure?
Repeated airway collapse can lower oxygen and trigger a stress response that raises blood pressure. Obstructive sleep apnea is especially common in people whose hypertension remains high despite medication, so evaluation and treatment may be important.
Does sleep apnea increase the risk of atrial fibrillation or stroke?
Obstructive sleep apnea is a major risk factor for atrial fibrillation, an irregular heart rhythm, and untreated apnea is associated with more recurrences after ablation. More severe apnea is also associated with greater stroke risk, although personal risk depends on age, blood pressure, and other health factors.
Can sleep apnea affect blood sugar or cause weight gain?
Sleep apnea can interfere with the body's response to insulin, increasing insulin resistance and type 2 diabetes risk even in people who are not overweight. Sleep loss can also increase hunger and weight gain, while extra weight around the neck can make airway obstruction worse.
Can I have sleep apnea if I am not sleepy during the day?
Yes. Many people with obstructive sleep apnea do not report marked daytime sleepiness, but they can still have repeated nighttime oxygen drops. The need for treatment depends on the severity of the breathing problem, oxygen levels, and other health conditions.
What does my AHI tell me about my sleep apnea risk?
AHI, or apnea-hypopnea index, measures how many breathing interruptions happen per hour of sleep. It helps describe severity, but the depth and duration of low oxygen, along with blood pressure and other conditions, also help determine cardiovascular risk.
Does CPAP reduce the long-term heart risks of sleep apnea?
CPAP keeps the airway open and reliably treats the obstruction when it is used. Its cardiovascular benefit depends heavily on using it consistently throughout the night, and evidence is mixed about whether it prevents heart attacks or strokes in people without daytime sleepiness.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my AHI, what is my specific risk for developing treatment-resistant hypertension or atrial fibrillation?
  2. 2.Since I don't feel very sleepy during the day, how should we monitor if OSA is still impacting my heart or blood sugar?
  3. 3.Can you explain how my 'hypoxic burden' (the total amount of time my oxygen is low) compares to my AHI?
  4. 4.Should I be screened for type 2 diabetes or insulin resistance given my OSA diagnosis?
  5. 5.How will we determine if my morning headaches or mood changes are directly linked to my sleep apnea?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

    Yeghiazarians Y, Jneid H, Tietjens JR, et al.

    Circulation 2021; (144(3)):e56-e67 doi:10.1161/CIR.0000000000000988.

    PMID: 34148375
  2. 2

    Association between obstructive sleep apnea and cardiovascular diseases.

    Li YE, Ren J

    Acta biochimica et biophysica Sinica 2022; (54(7)):882-892 doi:10.3724/abbs.2022084.

    PMID: 35838200
  3. 3

    Obstructive sleep apnea, cognition and Alzheimer's disease: A systematic review integrating three decades of multidisciplinary research.

    Bubu OM, Andrade AG, Umasabor-Bubu OQ, et al.

    Sleep medicine reviews 2020; (50()):101250 doi:10.1016/j.smrv.2019.101250.

    PMID: 31881487
  4. 4

    Polysomnographic characteristics of excessive daytime sleepiness phenotypes in obstructive sleep apnea: results from the international sleep apnea global interdisciplinary consortium.

    Thorarinsdottir EH, Pack AI, Gislason T, et al.

    Sleep 2024; (47(4)) doi:10.1093/sleep/zsae035.

    PMID: 38315511
  5. 5

    Clinical and Polysomnographic Correlates of Subjective Sleepiness in Mild Obstructive Sleep Apnea.

    Omobomi O, Batool-Anwar S, Quan SF

    Sleep and vigilance 2019; (3(2)):131-138 doi:10.1007/s41782-019-00068-2.

    PMID: 32201855
  6. 6

    The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome.

    Liu X, Ma Y, Ouyang R, et al.

    Journal of neuroinflammation 2020; (17(1)):229 doi:10.1186/s12974-020-01905-2.

    PMID: 32738920
  7. 7

    Excessive daytime sleepiness in obstructive sleep apnea: implications for driving licenses.

    Garbarino S

    Sleep & breathing = Schlaf & Atmung 2020; (24(1)):37-47 doi:10.1007/s11325-019-01903-6.

    PMID: 31342234
  8. 8

    Associations of Undiagnosed Obstructive Sleep Apnea and Excessive Daytime Sleepiness With Depression: An Australian Population Study.

    Lang CJ, Appleton SL, Vakulin A, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2017; (13(4)):575-582 doi:10.5664/jcsm.6546.

    PMID: 28095971
  9. 9

    Obstructive Sleep Apnea and Cardiometabolic Disease: Obesity, Hypertension, and Diabetes.

    Tasali E, Pamidi S, Covassin N, Somers VK

    Circulation research 2025; (137(5)):764-787 doi:10.1161/CIRCRESAHA.125.325676.

    PMID: 40811500
  10. 10

    Brain stem activity changes associated with restored sympathetic drive following CPAP treatment in OSA subjects: a longitudinal investigation.

    Lundblad LC, Fatouleh RH, McKenzie DK, et al.

    Journal of neurophysiology 2015; (114(2)):893-901 doi:10.1152/jn.00092.2015.

    PMID: 25995345
  11. 11

    Obstructive sleep apnea syndrome, continuous positive airway pressure and treatment of hypertension.

    Floras JS

    European journal of pharmacology 2015; (763(Pt A)):28-37.

    PMID: 26096557
  12. 12

    Atrial Fibrillation And Sleep Apnea: Considerations For A Dual Epidemic.

    Tung P, Anter E

    Journal of atrial fibrillation 2016; (8(6)):1283 doi:10.4022/jafib.1283.

    PMID: 27909488
  13. 13

    Obstructive Sleep Apnoea and Atrial Fibrillation.

    Zhang L, Hou Y, Po SS

    Arrhythmia & electrophysiology review 2015; (4(1)):14-8 doi:10.15420/aer.2015.4.1.14.

    PMID: 26835094
  14. 14

    Treating obstructive sleep apnea with continuous positive airway pressure reduces risk of recurrent atrial fibrillation after catheter ablation: a meta-analysis.

    Deng F, Raza A, Guo J

    Sleep medicine 2018; (46()):5-11 doi:10.1016/j.sleep.2018.02.013.

    PMID: 29773211
  15. 15

    Obstructive sleep apnea and its effects on cardiovascular diseases: a narrative review.

    Rivas M, Ratra A, Nugent K

    Anatolian journal of cardiology 2015; (15(11)):944-50 doi:10.5152/AnatolJCardiol.2015.6607.

    PMID: 26574763
  16. 16

    Sleep-disordered breathing in heart failure.

    Pearse SG, Cowie MR

    European journal of heart failure 2016; (18(4)):353-61 doi:10.1002/ejhf.492.

    PMID: 26869027
  17. 17

    Approach the Patient With Obstructive Sleep Apnea and Obesity.

    Meyer EJ, Wittert GA

    The Journal of clinical endocrinology and metabolism 2024; (109(3)):e1267-e1279 doi:10.1210/clinem/dgad572.

    PMID: 37758218
  18. 18

    Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction.

    Ryan S

    The Journal of physiology 2017; (595(8)):2423-2430 doi:10.1113/JP273312.

    PMID: 27901270
  19. 19

    Continuous Glucose Monitoring Among People with and without Diabetes Mellitus and Sleep Apnoea.

    Gouveri E, Drakopanagiotakis F, Panou T, et al.

    Diabetes therapy : research, treatment and education of diabetes and related disorders 2025; (16(8)):1533-1555 doi:10.1007/s13300-025-01756-1.

    PMID: 40465146
  20. 20

    Effect of obstructive sleep apnea syndrome on glycolipid metabolism and early atherosclerosis in diabetics.

    Wang J, Hu L, Wang Z, et al.

    Diabetes research and clinical practice 2020; (159()):107999 doi:10.1016/j.diabres.2020.107999.

    PMID: 31904443
  21. 21

    Visceral Obesity Mediates the Association Between Metabolic Syndrome and Obstructive Sleep Apnea Syndrome.

    Bozkurt NC, Beysel S, Karbek B, et al.

    Metabolic syndrome and related disorders 2016; (14(4)):217-21 doi:10.1089/met.2015.0086.

    PMID: 27003688
  22. 22

    Diagnosis and Management of Obstructive Sleep Apnea: A Review.

    Gottlieb DJ, Punjabi NM

    JAMA 2020; (323(14)):1389-1400 doi:10.1001/jama.2020.3514.

    PMID: 32286648
  23. 23

    Good long-term adherence to continuous positive airway pressure therapy in patients with resistant hypertension and sleep apnea.

    Campos-Rodriguez F, Navarro-Soriano C, Reyes-Nuñez N, et al.

    Journal of sleep research 2019; (28(5)):e12805 doi:10.1111/jsr.12805.

    PMID: 30604577
  24. 24

    Clinical perspective on non-sleepy obstructive sleep apnea; to treat or not to treat?

    Luu S, Nanayakkara B, Yee BJ

    Expert review of respiratory medicine 2026; (20(3)):227-239 doi:10.1080/17476348.2025.2539542.

    PMID: 40704845

This page is for informational purposes only and does not constitute medical advice. Discuss your symptoms, AHI, oxygen levels, and cardiovascular or metabolic risks with your clinician.

Get notified when new evidence is published on obstructive sleep apnea syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.